[Mass treatment of Schistomsoma haematobium bilharziasis in the member states of the Organization for Coordination of the Campaign against Endemic Diseases in Central Africa].

The authors analysed the results of the control of Schistosoma haematobium bilharziasis in two central African countries, the Congo and the Cameroun . These results demonstrated: --The feasibility of mass screening by filtering urine; --The acceptability and efficacy of new antibilharzian drugs, praziquantel and oltipraz . With the aim of improving the cost/effectiveness ratio of these campagnes and taking into account the health requirements which exist and/or are desired by the population, the authors propose four modifications of the strategy of mass control: --The integration of Schistosoma haematobium bilharziasis control with the other regional health priorities; --Screening target groups;